Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers

We evaluated antibody responses to the human immunodeficiency virus (HIV) envelope variable regions 1 and 2 (V1V2) in 29 vaccinees who had received three HIV-1 DNA immunizations and two HIV-modified vaccinia virus Ankara (MVA) boosts in the phase I/II HIVIS03 vaccine trial. Twenty vaccinees received...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Autores principales: Joachim, Agricola, Msafiri, Frank, Onkar, Sayali, Munseri, Patricia, Aboud, Said, Lyamuya, Eligius F., Bakari, Muhammad, Billings, Erik, Robb, Merlin L., Wahren, Britta, Mhalu, Fred S., Sandström, Eric, Rao, Mangala, Nilsson, Charlotta, Biberfeld, Gunnel
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711440/
https://ncbi.nlm.nih.gov/pubmed/33202967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040681
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares